Background. The treatment effects and safety of ear acupressure (EAP) for patients with allergic rhinitis (AR) have yet to be clarified. Objective. To evaluate the effects and safety of EAP in AR patients. Design. Systematic review of published studies. Methods. A total of 24 English and Chinese databases (PubMed, EMBASE (Excerpta Medical Database), Cochrane Central Register of Controlled Trials, CINAHL, Informit, ScienceDirect, LILACS (Latin American and Caribbean Health Sciences), ProQuest, AMED, Blackwell Synergy, PsycINFO, Panteleimon, AcuBriefs, KoreaMed, IndMed, Ingenta, mRCT, ISI Web of Knowledge, ERIC, VIP Information (http://www.cqvip.com), China National Knowledge Infrastructure (http://www.cnki.net), Cochrane Library, Chinese Cochrane Centre Controlled Trials Register Platform, and Wanfang Chinese Digital Periodical and Conference Database) were searched from their respective inceptions to August 2020 to collect randomized controlled trials of ear acupressure for allergic rhinitis. We performed literature inclusion, data extraction, and trial quality evaluations. Methodological quality was assessed according to the Cochrane Handbook. Revman5.3 was used for all analyses. Results. A total of 203 trials were identified and eleven studies involved 1094 participants aged 3–70 years. EAP was better than control group interventions in terms of effectiveness (risk ratio (RR): 0.51; 95% confidence interval (CI): 0.36–0.70; ). EAP was superior to sham EAP in terms of improvement of the total nasal symptom score (RR: −0.50; 95% CI: −0.96–0.05; P = 0.03), sneezing score (RR: −0.36; 95% CI: −0.59–0.12; P = 0.003), global QoL score (RR: 0.42; 95% CI: 0.04–0.08; P = 0.03), and eye symptom score (RR: −0.36; 95% CI: −0.67–0.05; P = 0.02). Conclusions. Despite the positive results, it is premature to confirm the efficacy of EAP for treating AR. More high-quality studies are needed to confirm safety and efficacy.
Due to recent advancement of AI and robotics technology, the research of intelligent wheelchair (iWheelChair) begins to draw attention from both scientific community and industry. WheelChair is a kind of home welfare tools and can help the handicapped and elderly people to gain mobility and lead to independent life. This paper describes a newly developed intelligent wheelchair. The controller of the iWheelChair adopts the advanced DSP technology, and plays the role of data acquisition and processing of joystick and ultrasonic sensors. 8 ultrasonic sensors are mounted on WheelChair and can detect the environment changes for safe operation. Experiments are presented to show that iWheelChair is able to avoid obstacles safely while controlled by its user via the joystick
Introduction: Radical gastrectomy with D2 lymph node dissection is the main surgical method for patients with resectable tumors. However, the effects of laparoscopic gastrectomy (LG) on Short-term clinical outcomes and long-term survival are still uncertainty for patients with advanced gastric cancer (AGC), compared with open gastrectomy (OG). The aim of this umbrella review is to provide a summary overview that evaluates the depth and strength of existing research evidence in order to clarify the potential benefits and harms of LG for AGC compared to OG. Methods and analysis: Systematic reviews and meta-analyses about LG versus OG for AGC will be retrieved comprehensively in PubMed, OVid, the Cochrane Library, Web Of Science, Wan Fang, CNKI and the SinoMed databases. Two authors will select studies according to pre-set criteria and evaluate the quality of the studies by using AMSTAR2 tool. Information obtained independently by two authors will be recorded in tabular form. The results of LG vs OG in each outcome will be summarized in narrative form. We will divide the evidence strength of each outcome into high, moderate, low, or very low quality according to Grading of Recommendations, Assessment, Development and Evaluation standard. Ethics and dissemination: Ethical approval as well as informed consent from patients will not be required. The findings of this research will be communicated through conferences, published in a peer-reviewed journal and disseminated through other digital media. Protocol registration number: (INPLASY2021120058).